Thirty healthy parturients, having given informed consent, were randomly allocated in a double-blind study to receive an intramuscular injection of either O. 9% sodium chloride (control), ephedrine 25 mg, or ephedrine 50 mg, 30 minutes prior to general anaesthesia for caesarean section. Nine patients (90%) in the 50 mg group and five patients (50%) in the 25 mg group demonstrated reactive hypertension of 20% or greater from control. The mean maximum increase in the 50 mg group was 28.2% (range 4.4-38.3%). Maternal pH was significantly lower (P= 0.03) in the ephedrine 50 mg group. Neonatal acid base status was significantly impaired in the ephedrine 50 mg group with umbilical venous pH (P= 0.0001) and umbilical arterial pH (P= 0.001) being significantly lower than the control group. The associated increase in umbilical arterial base deficit suggests a metabolic component due to fetal asphyxia related to decreased uterine blood flow. We conclude that the prophylactic administration of intramuscular ephedrine prior to spinal anaesthesia is associated with an unacceptably high incidence of maternal hypertension, and should the spinal fail and general anaesthesia be required, also results in adverse neonatal biochemical changes. The technique is therefore not to be recommended.
Spinal anaesthesia for caesarean section is associated with an unacceptably high incidence of hypotension despite the administration of crystalloid preload and the use of uterine displacement. Since prevention is better than treatment, some current textbooks suggest the prespinal administration of prophylactic vasopressor agents. I Ephedrine is recommended as the agent of choice as it has been shown not to cause a decrease in uterine bloodflow/ and Gutsche in 1976 recommended the use of prophylactic intramuscular ephedrine suggesting that such a regimen reduced the incidence of hypotension and improved neonatal outcome. 3 However, absorption from the intramuscular route is unpredictable, and there has been no study of onset, effect and duration of action of intramuscular ephedrine in pregnancy to suggest the correct dose and time of administration. A further concern with the administration of prophylactic ephedrine is the combination of effects of vasopressor and general anaesthesia upon the neonate in the event of failure of the spinal. Review of studies of spinal anaesthesia in obstetric patients suggests a failure rate up to 4.5%. 4 The aim of this study was to document the timing and extent of maternal haemodynamic changes after intramuscular injection of ephedrine to ensure the lack of any adverse effects upon neonatal outcome following subsequent general anaesthesia.
PATIENTS AND METHODS The study protocol was approved by the Faculty of Medicine, University of Natal, Professional Standards and Ethics Committee. Thirty healthy parturients with normal pregnancies presenting for elective caesarean section under general anaesthesia at term were studied. It was emphasised to the patients that the injections used in the study would offer no advantage to either mother or baby but that available evidence suggested that they should not be harmful. Having agreed to participate in the study and having given informed consent, patients were randomly allocated to receive intramuscular injections of 0.9% sodium chloride (control group), ephedrine 25 mg, or ephedrine 50 mg. Values are expressed as mean (SD). There were no significant differences between groups.
All patients had uterine displacement maintained throughout the study period via an obstetric wedge under the right buttock. An intravenous cannula was inserted under local anaesthesia in the left forearm and a slow infusion of Plasmalyte-L commenced. After a period of rest, the cuff of an automated non-invasive blood pressure monitor (Critikon Dinamap) was placed around the right arm and blood pressure and heart rate monitored at three-minute intervals to obtain baseline readings. The mean of three values was used provided that the systolic pressure did not vary by greater than 10%.
Following baseline readings, patients received an intramuscular injection into the left deltoid. All injections were drawn up as 1.0 ml and contained either sodium chloride 0.9%, ephedrine 25 mg or ephedrine 50 mg. The observer was unaware of the nature of the injection which had been drawn by a colleague on a randomised basis. Following injection, blood pressure and heart rate were recorded at two-minute intervals for a period of thirty minutes.
Patients were then moved into the operating room and placed on the operating table in the left supine wedged position having received sodium citrate 30 ml 0.3 M and metoclopramide to mg IV.
Patients were preoxygenated for three minutes whereafter thiopentone 4 to 5 mg.kg-1 was administered. Cricoid pressure was applied following loss of consciousness and suxamethonium 1.0 mg.kg -I was given to facilitate endotracheal intubation.
Anaesthesia was maintained with nitrous oxide (50%) in oxygen and 0.8% enflurane, and patients were mechanically ventilated using a rebreathing system with a fresh gas flow calculated to maintain a PaC02 of 4.3 kPa. Muscle relaxation was maintained with intermittent suxamethonium, monitored by a peripheral nerve stimulator, and analgesia was provided following delivery by 10 to 15 mg papaveretum given intravenously.
Maternal arterial (radial artery sample) and umbilical venous and arterial blood was obtained at delivery and analysed for blood gas and acidbase status. Neonates were assessed at I and 5 minutes from delivery using a modified Apgar scoring system (Apgar minus colour). Times of induction, uterine incision and delivery (first cord clamp) were recorded.
Results were analysed using one-way analysis of variance with a repeated measures design and the Duncan multiple range test for between-group comparisons, and paired t test for within-group comparisons.
RESULTS
Thirty patients, ten in each group, were studied. The groups were comparable with regard to maternal age, weight, induction to delivery and uterine incision to delivery times, and baseline blood pressures and heart rate (Table I) . Systolic   TABLE 2 Maximum percentage increase in systolic blood pressure achieved in each group, time taken to achieve the maximum and time taken to achieve greater than 20% of the baseline value.
Maximum increase (%) Time to maximum (min) Time to > 20% (min) pressures, which are expressed as a percentage of baseline values, showed no significant differences in the control group (Figure 1 ). Patients who received ephedrine 25 mg had significant (paired t test, P< 0.05) increases from baseline at 6, 14 and 22 to 28 minutes. Patients receiving ephedrine 50 mg showed significant increases at all times following injection. Analysis of variance between the groups showed that the increased systolic pressure in patients receiving ephedrine 50 mg was significantly greater at 2 minutes and from 6 to 30 minutes compared with the control group, and at 2 minutes, 8 to 20 minutes and 30 minutes compared to the 25 mg group. Maximum percentage increases in systolic blood pressure, time taken to achieve maximum and time to achieve a 20% increase above baseline are shown in Table 2 .
Heart rate changes were more variable and while there was a trend towards an increased heart rate in patients receiving ephedrine, the only statistically significant increases occurred in the ephedrine 50 mg group at 6, 14 and 18 minutes post injection. There were no statistically significant differences between the groups.
Maternal and umbilical blood gas and acid base status at delivery are shown in Table 3 . Data sets were not complete in all cases. One patient from the ephedrine 25 mg group was removed from analysis because of a leak in the anaesthetic breathing circuit which led to maternal hypercarbia and acidosis. Maternal pH was significantly lower (P = 0.03) in patients who received ephedrine 50 mg compared with the other two groups. Repeated analysis of variance using maternal PaC02 and maternal standard base excess as covariates showed that both might have contributed to the maternal acidosis. Umbilical venous (Uv) pH was significantly (P= 0.001) lower in the ephedrine 50 mg group than both other groups and Uv PC02 was significantly higher (P = 0.05). Standard base deficit was significantly greater in the 50 mg group (P = 0.02) compared with the control group. Umbilical arterial analysis showed a lower pH in both groups of patients receiving ephedrine compared with controls (P= 0.0001). Umbilical arterial (Ua) PC02 was higher than controls in the ephedrine 50 mg group (P = 0.005) and standard base deficit was greater than in both the other groups (P= 0.021). There was still a significant difference (P = 0.01) in umbilical arterial pH between the groups when maternal arterial pH was used as a covariate, but the difference was no longer significant when umbilical venous pH was also taken into account (P= 0.076).
There were no Apgar (A-colour) scores lower than 7 except for one neonate in the control group who had a one-minute score of 4. The only apparent reason for this was that the umbilical cord was wrapped twice around the neck. The neonate in the case withdrawn from analysis had a one-minute A-C score of 8 despite an umbilical venous pH of 7.1.
DISCUSSION
While the use of intravenous bolus doses of ephedrine to treat post-spinal hypotension is wellestablished, the use of prophylactic vasopressors prior to the administration of spinal anaesthesia remains controversial. In a study of prophylactic intramuscular ephedrine, Gutsche concluded that fluid preloading and left uterine displacement were inadequate to prevent post-spinal hypotension, and that the use of intramuscular ephedrine reduced the subsequent incidence of hypotension with an improved neonatal outcome. 3 Prophylactic intramuscular ephedrine is associated with reactive hypertension 5 and unpredictable absorption,6 and in addition there is the possibility that the spinal anaesthetic will fail necessitating general anaesthesia. The use of prophylactic intramuscular ephedrine before the establishment of adequate spinal anaesthesia would subject a significant number of patients to the combined effects of ephedrine and general anaesthesia. To our knowledge, the influence of ephedrine on neonatal outcome following general anaesthesia has not been studied.
In the 25 mg group, five patients (50%) failed to increase the systolic blood pressure to greater than 20% of baseline. It is unlikely that, in the event of spinal blockade, post-spinal hypotension would Anaesthesia and Intensive Care. Vol. 20. No. 4. November. 1992 have been prevented in these patients. In addition, in the five patients who achieved a 20% increase in systolic blood pressure, the mean time to achieve this increase was 14.8 minutes (range 6-26 minutes). This time delay which was also present in the 50 mg group (14.4 min; range 8-22 min) would preclude the use of intramuscular ephedrine immediately following the spinal injection, as postspinal hypotension usually occurs within the first ten minutes. A 20% systolic increase was achieved in nine (90%) of the 50 mg group. The mean maximum increase in systolic pressure in this group was 28% with a range of 4.4-38.3%, the higher levels being clinically unacceptable. Five patients showed an increase of greater than 30%.
With regard to the fetus, the administration of vasopressors without subsequent regional anaesthesia has only been studied in animals. Ralston, Shnider and de Lorimier2 studied the effects of four vasopressors in chronically implanted unanaesthetised pregnant ewes, and found that even at high doses (producing an increase in mean arterial pressure > 50%), ephedrine had no effect on uterine blood flow or fetal status, whereas agents with a predominantly alpha-adrenergic action caused reductions in uterine blood flow. They also noted that there were no significant changes in fetal blood gases and acid base status despite reductions of uterine blood flow of 50 to 60% for as long as 5 minutes, suggesting a wide margin of safety with ephedrine. Conclusions from results in animals with syndesmochorial placentas however may not be directly relevant to humans. In a study of vasopressor infusions in pregnant baboons and Macaque monkeys, Eng et al. 7 showed that there might be a time-related decrease in uterine blood flow one hour following ephedrine infusion, although during the infuson there was no significant change. As there was no parallel control group in their study, the changes they saw might be explained by a time-based deterioration of the experimental preparation, which is a recognised problem. 8 They also commented upon fetal heart rate changes suggesting transplacental passage of ephedrine. Despite their inability to endorse the use of prophylatic ephedrine, they conclude that ephedrine is a relatively innocuous drug to give in the presence of normotension.
Studies of prophylactic ephedrine prior to epidural anaesthesia 5 ,9 have produced conflicting results. Ward and colleagues 9 demonstrated no adverse effects on the mother or neonate of 25 mg or 50 mg of intramuscular ephedrine prior to epidural anaesthesia. Umbilical venous and arterial blood gas analysis were reported as within normal limits, but there was no group of control subjects for comparison. Rolbin, 5 on the other hand, demonstrated an unacceptably high incidence of maternal hypertension in patients receiving ephedrine 50 mg and also reported a mean umbilical arterial pH of 7.18 (0.02) in the same subjects which was significantly lower than in the control subjects receiving saline.
The results of our study demonstrate a significant effect of ephedrine on umbilical blood gas and acid base status of babies delivered by general anaesthesia. Although there were statistically significant differences between the groups in several variables, all but the Ua pH (ephedrine 50 mg) were within our normal reference ranges for general anaesthesia, and in view of the good neonatal clinical condition in all cases, might not be considered as clinically significant. While neonatal neurobehavioural testing might have detected small differences between the groups, this was not the case in Rolbin's study.s The lower mean umbilical arterial pH of 7.16 in the ephedrine 50 mg group is both statistically and clinically significant. The increase in Ua base deficit (to greater than Uv base deficit) in this group suggests a metabolic component due to fetal asphyxia. That this was largely due to decreased uterine blood flow is suggested by the lower Ua pH in this group and the influence ofUv pH when used as a covariate.
None of our patients was fluid preloaded, and it is possible that the use of an intravenous fluid preload, which is the normal practice prior to spinal anaesthesia, would have improved umbilical acid base status. In the study outlined above a mean Ua pH (7.18) similar to the value in our study in patients receiving 50 mg of ephedrine was obtained. 5 All patients in this study had received a litre of crystalloid fluid preload. However, the validity of comparison of epidural anaesthesia with general anaesthesia in this context is questionable.
The study reported here was designed to investigate the timing and duration of action of intramuscular ephedrine and its effect upon placental gas exchange in the event of general anaesthesia, prior to incorporating its use as part of a spinal anaesthesia protocol. While the numbers of subjects in the study are small, we felt that the effect upon placental gas exchange was serious enough to warrant discontinuation. The delayed absorption from the intramuscular site necessitates the administration of prophylactic ephedrine prior to induction of spinal blockade. If a general anaesthetic has to be given, the ephedrine may have an adverse effect on neonatal acid base status. While this may represent only a small proportion of cases (up to 4.5%), the additional risk in these patients is not justified by the cardiovascular responses following injection, which were inadequate in 50% of patients receiving 25 mg and excessive in 50% of patients receiving 50 mg. The latter would imply an unacceptable hypertensive response in patients who were destined not to develop post-spinal hypotension.
